Association between vitamin D and COVID-19 infection and mortality in Taiwanese patients
Ching-Ching Sheng, Shuan-Yi Su, Ying Liang, Hui-Chuan Cheng, Hsin-Yi Huang, correspondence. Rn Hsiao-Hui Chiu
Journal of the Chinese Medical Association, doi:10.1097/jcma.0000000000001294
Background: Vitamin D plays a role in immune regulation and may influence COVID-19 outcomes. This study examined the association between serum vitamin D levels with COVID-19 infection and mortality in symptomatic patients in Taiwan. Methods: This retrospective cohort study included symptomatic patients who underwent COVID-19 real-time polymerase chain reaction (RT-PCR) assay between 2020 and 2023. Serum 25-hydroxyvitamin D (25(OH)D) levels were categorized as deficient (<20 ng/mL), insufficient (20-30 ng/mL), or sufficient (≥30 ng/mL). Logistic regression models were used to evaluate the impact of vitamin D levels on COVID-19 infection and mortality, adjusting for potential confounders including age, sex, and comorbidities. Results: Among the 481 participants (mean age 58.2 years; 66.7% female), 96 (19.96%) tested positive for COVID-19. Vitamin D level was not associated with COVID-19 infection (OR=1.00, 95% CI: 0.99-1.02, p=0.687), however vitamin D deficiency significantly increased the risk of COVID-19-related mortality (OR=10.68, 95% CI: 1.18-96.45; p=0.035). The mortality rate in patients aged 65-74 years was higher compared to those aged 19-44 years (OR=12.91, 95% CI: 1.29-128.83; p=0.029). Conclusions: Vitamin D levels were not associated with susceptibility to COVID-19 infection. However, vitamin D deficiency, particularly in older patients, was associated with an increased risk of mortality among those diagnosed with COVID-19. These findings support the role of vitamin D in reducing COVID-19 mortality, and emphasize the importance of maintaining sufficient levels in high-risk populations.
References
Alguwaihes, Sabico, Hasanato, Me, Megdad et al., Severe vitamin d deficiency is not related to sars-cov-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an arab gulf country, Aging Clin Exp Res
Aranow, Vitamin D and the immune system, J Investig Med
Athanassiou, Kostoglou-Athanassiou, Nikolakopoulou, Konstantinou, Mascha et al., Vitamin D levels as a marker of severe SARS-CoV-2 infection, Life
Bassatne, Basbous, Chakhtoura, El Zein, Rahme et al., The link between COVID-19 and vitamin d (vivid): a systematic review and meta-analysis, Metabolism
Bianconi, Mannarino, Figorilli, Cosentini, Batori et al., Prevalence of vitamin d deficiency and its prognostic impact on patients hospitalized with COVID-19, Nutrition
Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D status and sars-cov-2 infection and COVID-19 clinical outcomes, Front Public Health
Fantini, Corinaldesi, Lenzi, Migliaccio, Crescioli, Vitamin D as a shield against aging, International Journal of Molecular Sciences
Gibson-Moore, Vitamin D: What's new a year on from the COVID-19 outbreak?, Nutr Bull
Hafezi, Sharif-Askari, Sharif-Askari, Hussain Alsayed, Alsafar et al., Vitamin D enhances type i ifn signaling in COVID-19 patients, Sci Rep
Ismailova, White, Vitamin D, infections and immunity, Rev Endocr Metab Disord
Katz, Yue, Xue, Increased risk for COVID-19 in patients with vitamin D deficiency, Nutrition
Kaya, Pamukçu, Yakar, The role of vitamin d deficiency on COVID-19: A systematic review and meta-analysis of observational studies, Epidemiol Health
Malaguarnera, Vitamin D3 as potential treatment adjuncts for COVID-19, Nutrients
Mistry, Barmania, Mellet, Peta, Strydom et al., SARS-CoV-2 variants, vaccines, and host immunity, Front Immunol
Shah, Varna, Sharma, Mavalankar, Does vitamin D supplementation reduce COVID-19 severity?: A systematic review, Qjm
Smaha, Kužma, Jackuliak, Nachtmann, Max et al., Serum 25hydroxyvitamin D concentration significantly decreases in patients with COVID-19 pneumonia during the first 48 hours after hospital admission, Nutrients
Znaidia, Demeret, Van Der Werf, Komarova, Characterization of SARS-CoV-2 evasion: Interferon pathway and therapeutic options, Viruses
DOI record:
{
"DOI": "10.1097/jcma.0000000000001294",
"ISSN": [
"1726-4901"
],
"URL": "http://dx.doi.org/10.1097/JCMA.0000000000001294",
"abstract": "<jats:sec>\n <jats:title>Background:</jats:title>\n <jats:p>Vitamin D plays a role in immune regulation and may influence COVID-19 outcomes. This study examined the association between serum vitamin D levels with COVID-19 infection and mortality in symptomatic patients in Taiwan.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Methods:</jats:title>\n <jats:p>This retrospective cohort study included symptomatic patients who underwent COVID-19 real-time polymerase chain reaction (RT-PCR) assay between 2020 and 2023. Serum 25-hydroxyvitamin D (25(OH)D) levels were categorized as deficient (<20 ng/mL), insufficient (20–30 ng/mL), or sufficient (≥30 ng/mL). Logistic regression models were used to evaluate the impact of vitamin D levels on COVID-19 infection and mortality, adjusting for potential confounders including age, sex, and comorbidities.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Results:</jats:title>\n <jats:p>Among the 481 participants (mean age 58.2 years; 66.7% female), 96 (19.96%) tested positive for COVID-19. Vitamin D level was not associated with COVID-19 infection (OR=1.00, 95% CI: 0.99–1.02, <jats:italic toggle=\"yes\">p</jats:italic>=0.687), however vitamin D deficiency significantly increased the risk of COVID-19-related mortality (OR=10.68, 95% CI: 1.18–96.45; <jats:italic toggle=\"yes\">p</jats:italic>=0.035). The mortality rate in patients aged 65–74 years was higher compared to those aged 19–44 years (OR=12.91, 95% CI: 1.29–128.83; <jats:italic toggle=\"yes\">p</jats:italic>=0.029).</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Conclusions:</jats:title>\n <jats:p>Vitamin D levels were not associated with susceptibility to COVID-19 infection. However, vitamin D deficiency, particularly in older patients, was associated with an increased risk of mortality among those diagnosed with COVID-19. These findings support the role of vitamin D in reducing COVID-19 mortality, and emphasize the importance of maintaining sufficient levels in high-risk populations.</jats:p>\n </jats:sec>",
"author": [
{
"affiliation": [
{
"name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC"
},
{
"name": "Department of Nursing, Chang Jung Christian University, Tainan, Taiwan, ROC"
}
],
"family": "Sheng",
"given": "Ching-Ching",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC"
}
],
"family": "Su",
"given": "Shuan-Yi",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC"
}
],
"family": "Liang",
"given": "Ying",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC"
}
],
"family": "Cheng",
"given": "Hui-Chuan",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Information Management, Taipei Veterans General Hospital, Taipei, Taiwan, ROC"
}
],
"family": "Huang",
"given": "Hsin-Yi",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC"
},
{
"name": "Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan, ROC"
},
{
"name": "School of Nursing, National Defense Medical Center, Taipei, Taiwan, ROC"
}
],
"family": "Chiu",
"given": "Hsiao-Hui",
"sequence": "additional"
}
],
"container-title": "Journal of the Chinese Medical Association",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"lww.com",
"ovid.com"
]
},
"created": {
"date-parts": [
[
2025,
9,
12
]
],
"date-time": "2025-09-12T11:01:19Z",
"timestamp": 1757674879000
},
"deposited": {
"date-parts": [
[
2025,
9,
12
]
],
"date-time": "2025-09-12T11:01:20Z",
"timestamp": 1757674880000
},
"indexed": {
"date-parts": [
[
2025,
9,
12
]
],
"date-time": "2025-09-12T15:44:09Z",
"timestamp": 1757691849531,
"version": "3.44.0"
},
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2025,
9,
12
]
]
},
"language": "en",
"link": [
{
"URL": "https://journals.lww.com/10.1097/JCMA.0000000000001294",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "276",
"original-title": [],
"prefix": "10.1097",
"published": {
"date-parts": [
[
2025,
9,
12
]
]
},
"published-online": {
"date-parts": [
[
2025,
9,
12
]
]
},
"publisher": "Ovid Technologies (Wolters Kluwer Health)",
"reference-count": 0,
"references-count": 0,
"relation": {},
"resource": {
"primary": {
"URL": "https://journals.lww.com/10.1097/JCMA.0000000000001294"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Association between vitamin D and COVID-19 infection and mortality in Taiwanese patients",
"type": "journal-article",
"update-policy": "https://doi.org/10.1097/lww.0000000000001000"
}